Preferences of patients and physicians in the United States for relapsed/refractory follicular lymphoma treatments
Although PFS was the most important attribute to patients and physicians, both would tolerate lower PFS for reduced side effects. Patients would also accept a substantial reduction in PFS for oral administration. Differences between the preferences/priorities of patients and physicians highlight the importance of shared decision-making.
Authors
- Caitlin Thomas (ORCID: https://orcid.org/0000-0002-2314-714X)
- Deborah Lycett (ORCID: https://orcid.org/0000-0002-4525-6419)
- Myrto Trapali
- Nicolas Krucien (ORCID: https://orcid.org/0000-0001-9179-6558)
- Kevin Marsh (ORCID: https://orcid.org/0000-0002-7912-9485)
- Paul Cockrum
- Gavin Worth
Institutions
- Ipsen (France) (FR)
- Ipsen (United States) (US)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1002/cam4.70177
- Citations
- 5
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.12
Funders
- University of Pittsburgh
- Ipsen